Juvenescence Ltd
Insider CIK 1724307 · AGE Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| SER Serina Therapeutics, Inc. | A Award deriv | 2025-01-31 | 2025-02-03 | 377,864 | — | $0 | 755,728 | SEC↗ |
| SER Serina Therapeutics, Inc. | A Award | 2025-01-31 | 2025-02-03 | 500,000 | $10.00 | $5.00M | 3,267,188 | SEC↗ |
| SER Serina Therapeutics, Inc. | A Award deriv | 2024-11-27 | 2025-02-03 | 377,864 | — | $0 | 377,864 | SEC↗ |
| SER Serina Therapeutics, Inc. | D To issuer deriv | 2024-11-27 | 2025-02-03 | 755,728 | — | $0 | 0 | SEC↗ |
| SER Serina Therapeutics, Inc. | A Award | 2024-11-27 | 2025-02-03 | 500,000 | $10.00 | $5.00M | 2,767,188 | SEC↗ |
| SER Serina Therapeutics, Inc. | A Award deriv | 2024-06-06 | 2025-02-03 | 377,865 | — | $0 | 377,865 | SEC↗ |
| SER Serina Therapeutics, Inc. | M Exercise deriv | 2024-06-06 | 2025-02-03 | 377,865 | — | $0 | 755,728 | SEC↗ |
| SER Serina Therapeutics, Inc. | M Exercise | 2024-06-06 | 2025-02-03 | 377,865 | $13.20 | $4.99M | 2,267,188 | SEC↗ |
| AGE AgeX Therapeutics, Inc. | A Award deriv | 2023-04-25 | 2023-05-18 | 756,429 | — | $0 | 756,429 | SEC↗ |
| AGE AgeX Therapeutics, Inc. | G Gift | 2023-03-14 | 2023-03-22 | 16,447,500 | — | $0 | 0 | SEC↗ |
| AGE AgeX Therapeutics, Inc. | A Award deriv | 2023-02-16 | 2023-02-17 | 801,924 | — | $0 | 801,924 | SEC↗ |
| AGE AgeX Therapeutics, Inc. | A Award deriv | 2023-02-07 | 2023-02-08 | 340,136 | — | $0 | 340,136 | SEC↗ |
| AGE AgeX Therapeutics, Inc. | A Award deriv | 2022-12-19 | 2022-12-19 | 847,457 | — | $0 | 847,457 | SEC↗ |
| AGE AgeX Therapeutics, Inc. | A Award deriv | 2022-10-26 | 2022-10-27 | 362,318 | — | $0 | 362,318 | SEC↗ |
| AGE AgeX Therapeutics, Inc. | A Award deriv | 2022-08-24 | 2022-08-24 | 746,380 | — | $0 | 746,380 | SEC↗ |
| AGE AgeX Therapeutics, Inc. | A Award deriv | 2022-07-11 | 2022-08-24 | 703,234 | — | $0 | 703,234 | SEC↗ |
| AGE AgeX Therapeutics, Inc. | A Award deriv | 2022-04-14 | 2022-04-14 | 568,440 | — | $0 | 568,440 | SEC↗ |
| AGE AgeX Therapeutics, Inc. | A Award deriv | 2022-03-09 | 2022-03-11 | 5,230,768 | — | $0 | 5,230,768 | SEC↗ |
| AGE AgeX Therapeutics, Inc. | P Buy deriv | 2022-02-03 | 2022-02-14 | 308,565 | — | $0 | 308,565 | SEC↗ |
| AGE AgeX Therapeutics, Inc. | P Buy deriv | 2021-02-05 | 2021-02-09 | 263,852 | — | $0 | 263,852 | SEC↗ |
| AGE AgeX Therapeutics, Inc. | P Buy deriv | 2021-01-08 | 2021-01-12 | 328,947 | — | $0 | 328,947 | SEC↗ |
| AGE AgeX Therapeutics, Inc. | P Buy deriv | 2020-11-11 | 2020-11-19 | 280,898 | — | $0 | 280,898 | SEC↗ |
| AGE AgeX Therapeutics, Inc. | P Buy deriv | 2020-10-02 | 2020-10-06 | 588,235 | — | $0 | 588,235 | SEC↗ |
| AGE AgeX Therapeutics, Inc. | P Buy deriv | 2020-07-27 | 2020-07-30 | 375,939 | — | $0 | 375,939 | SEC↗ |
| AGE AgeX Therapeutics, Inc. | P Buy deriv | 2020-06-11 | 2020-06-16 | 541,125 | — | $0 | 541,125 | SEC↗ |
| AGE AgeX Therapeutics, Inc. | P Buy deriv | 2020-05-15 | 2020-06-16 | 714,285 | — | $0 | 714,285 | SEC↗ |
| AGE AgeX Therapeutics, Inc. | P Buy deriv | 2020-04-01 | 2020-04-03 | 268,817 | — | $0 | 268,817 | SEC↗ |
| AGE AgeX Therapeutics, Inc. | P Buy deriv | 2019-08-13 | 2019-08-15 | 150,000 | — | $0 | 150,000 | SEC↗ |
| AGE AgeX Therapeutics, Inc. | P Buy | 2019-08-13 | 2019-08-15 | 19,000 | — | $0 | 16,419,000 | SEC↗ |